VCEL...news is out. Positive secondary endpoint data for their cardio therapy. No noticeable stock reaction. Guess we'll have to wait the MACI pre-approval run-up.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.